Combination of PacBio’s HiFi Sequencing Capabilities and Form Bio’s Computational Platform and Solutions Helps Biopharma and Academic Researchers Innovate and Accelerates Gene Therapy Product Development

DALLAS, April 19, 2023 (Newswire.com)
–
Form Bio, the provider of advanced computational life sciences technology, today announced it has joined the PacBio Compatible program. As part of the program, the Form Bio platform has been verified as compatible with PacBio’s HiFi sequencing solutions, empowering corporate and academic research teams with a dramatically streamlined path from HiFi read data to breakthrough insights.

In particular, AAV-based gene therapy can address the underlying genetic problems that cause disease and holds great promise to help improve human health. With the combination of Form Bio’s data analysis capabilities and PacBio’s sequencing solutions, scientists can enhance their understanding of the genetic components underlying disease and ultimately improve AAV gene therapies in their application to a vast spectrum of diseases.

PacBio is a developer of high-quality, highly accurate sequencing solutions, providing the advantage of being able to sequence entire, intact constructs with high accuracy. The ability to produce full length reads is important for AAV gene therapy discovery and for confirming the quality of these constructs.

By combining PacBio’s HiFi sequencing capabilities with Form Bio’s innovative computational platform and solutions, mutual customers can not only accelerate but also advance and enhance the quality of research that relies on full read data. In addition, the Form Bio platform includes access to an optimized AAV PacBio QC workflow for characterizing the quality of AAV vector manufacturing.

“We’re thrilled to team up with PacBio to help advance gene therapy discovery and development,” said Kent Wakeford, co-CEO for Form Bio. “This partnership brings together our technology and expertise to provide an ‘easy button’ for PacBio customers, who are looking to get the most out of their HiFi sequencing data but face practical constraints with bioinformatics or computational resources.”

“We share Form Bio’s vision to help scientists and gene therapy developers move the industry forward, making this partnership a natural fit,” said Jeff Eidel, chief commercial officer for PacBio. “Form Bio’s powerful platform, advanced AI-based solutions and uniquely strong combination of both life science and data science expertise all add tremendous value to how researchers utilize PacBio products and solutions.”

To learn more about how Form Bio and PacBio solutions work together, visit https://formbio.com/pacbio. 

About Form Bio

Form Bio is a cutting-edge research and discovery platform for individuals and enterprises in life sciences. With an accessible, comprehensive and collaborative platform, Form Bio empowers scientists to efficiently and effectively harness the proliferation of data and computing power that has transformed the science of discovery. Form offers end-to-end integration of the discovery process with intuitive and easy-to-use software applications, combined with an open and adaptable collaborative environment. For more information on Form Bio, visit www.formbio.com

Contact Information:

Maggie Whitney

Senior Public Relations Executive

[email protected]

2039571502

Alison Guzzio

Public Relations Director

[email protected]

4844593243

Original Source:

Form Bio Joins PacBio Compatible Program to Accelerate Gene Therapy Research From Data to Insights

New technology will better serve aging and disability communities in Tennessee

NASHVILLE, Tenn., April 18, 2023 (Newswire…

Brightstar Therapeutics Logo

LEXINGTON, Ky., April 18, 2023 (Newswire.com)
–
Brightstar Therapeutics, a biotechnology company focused on providing inno…

Black Book Research acknowledges the top-performing hospital technology companies within various clinical market segments based on the industry’s largest client survey of inpatient providers at the Healthcare Information Management Systems Society annual conference in Chicago this week.

CHICAGO, April 17, 2023 (Newswire.com)
–
Black Book Research, the premier source of unbiased, crowdsourced, competitive intelligence, and buyer opinion mining serving the technology and managed services sectors, announces the first round of 2023 awards for highest hospital user experience and clinician satisfaction. Black Book survey results released today include EHR, Population Health, Clinical Department Support, Nursing, Patient Engagement, and Interoperability. The 2023 Black Book awards for Revenue Cycle Management, Finance, Analytics, Cybersecurity, and AI categories will be announced in May.

“Black Book is committed to innovative research, customer satisfaction, loyalty polling, and analysis of the strategic buyer issues in the healthcare marketplace free from the influence of vendors,” said Doug Brown, President of the firm. “It is an exciting time at Black Book, as our team is introducing unrivaled user experience surveying tools, the industry’s most robust client satisfaction database, innovative reporting functionalities, and a knowledge management system that enables customers to share relevant, informed feedback in real-time.” 

Black Book, its founders, owners nor its employees hold any financial interest in the companies contained in any comparison performance report and is not incentivized to recommend any of the ten thousand healthcare industry products and services vendors collected for the last decade. 

The highest-scoring hospital IT and support suppliers in the past year’s Black Book client experience polls with HIMSS23 trade show presence are recognized with their exhibit hall booth number:

1UPHEALTH (4357)

ACCENTURE (1725)

AGFA (1902)

ALTERA DIGITAL HEALTH (4053)

AMAZON WEB SERVICES (2056)

AMWELL (3306)

ANDOR HEALTH (2875)

ARCADIA.IO (152)

AT&T  (931)

ATHENAHEALTH (2031)

BAKER TILLY (452)

BAMBOO HEALTH (7943)

BAXTER HEALTHCARE (4071)

BD (1248)

BEST BUY HEALTH (7506)

BIOFOURMIS (7319)

CAPSA HEALTHCARE (2844)

CARE.AI (3431)

CAREGILITY  (6815)

CDW HEALTHCARE (1263)

CENTRAK (134)

CHIPSOFT (3316)

CITIUSTECH (2812)

CROWDSTRIKE (4327)

DELOITTE (1209)

ENLITIC (7316)

EPIC SYSTEMS (956)

EVRY USA TIETOEVRY (6025)

FINTHRIVE (3670)

FORTINET (873)

HURON (1931)

HYLAND (1255)

IBM (2681)

IMPRIVATA (1841)

INFOR (967)

INNOVACCER (2216)

INTELICHART (3406)

INTERFACEWARE (3474)

INTERSYSTEMS (942)

IQVIA (8221)

LEIDOS (1221)

LIGHTBEAM HEALTH SOLUTIONS (3401)

LINUS HEALTH (438)

MDCLONE (4303)

MICROSOFT CLOUD (1201)

NETSMART (7946-53)

NEXTGEN HEALTHCARE (7946-66)

NUANCE (912)

OPTUM (1231)

ORACLE HEALTH   (921)

PHILIPS (901)

PHREESIA (8300-25)

PROOFPOINT (145)

PWC (3434)

RAD AI (7119)

REDOX (2638)

REVSPRING (2248)

SALESFORCE (2606)

SCC SOFT (1736)

SNOWFLAKE (8115)

SPOK  (2586)

SYMPLR (1867)

TEGRIA (1481)

THE SSI GROUP (319)

TYTOCARE   (3809)

UIPATH (7140)

VERADIGM  (3681)

VERIZON (4048)

WAYSTAR (2267)

WOLTERS KLUWER (431)

XIFIN (3631)

For a full list of Black Book’s top-ranked hospital category leaders (EHR, Population Health, Clinical Department Support, Nursing, and AI), visit http://www.blackbookmarketresearch.com

About Black Book™
Black Book Market Research LLC, provides healthcare decision makers, IT users, media, investors, analysts, quality-minded vendors, prospective software system buyers, pharmaceutical manufacturers, and other interested sectors of the clinical technology industry with comprehensive comparison data of the industry’s top respected and competitively performing technology and managed services vendors in the sector.

The largest user opinion poll of its kind in healthcare IT, the Black Book™ database of user satisfaction houses over 2,000,000 viewpoints on information technology, capital equipment, emerging technology, consulting firms, and outsourced services vendor performance with thousands of updates added every week throughout the year. For methodology, auditing, resources, comprehensive research, and ranking data, see http://www.blackbookmarketresearch.com

Contact Information:

Press Office

[email protected]

8008637590

Original Source:

The 70 Top Client-Rated Hospital Technologies Exhibiting at HIMSS23, Black Book Clinical User Survey Results

SAN DIEGO, April 17, 2023 (Newswire.com)
–
Genome Insight, a leading precision medicine and genomics company, announced that their innovative whole genome sequencing (WGS) approach will be featured in six poster presentations at the American Association of Cancer Research (AACR) Annual Meeting 2023 in Orlando, FL. These posters cover a range of topics, including a study of integrative biomarker analysis of regorafenib plus nivolumab (RegoNivo) in hepatocellular carcinoma (HCC), as well as a comparison between whole-genome sequencing-based and targeted panel sequencing approaches to precision oncology.

One notable presentation highlights that Genome Insight’s WGS approach provides a more thorough analysis of genetic mutations in breast cancers with homologous recombination deficiency (HRD) than traditional BRCA gene testing. WGS can accurately classify HR status and identify which patients would benefit from polymerase enzymes (PARP) inhibitor treatment, making it a fast and effective screening tool.

“We are thrilled to present our WGS approach at the AACR annual meeting, which demonstrates the potential of our innovative approach to impact clinical decision-making for patients with cancer.” – Dr. Young Seok Ju, CEO of Genome Insight

For more information about Genome Insight’s WGS approach and other services, visit www.genomeinsight.net.

About Genome Insight 

Genome Insight is a precision medicine whole genome platform company with the goal to accelerate the use of whole genome sequencing (WGS) for accurate diagnosis and personalized treatment for cancer and rare diseases. Genome Insight’s proprietary platform is an automated WGS pipeline coupled with a bioinformatics-powered digital solution that rapidly generates meaningful medical insights, making it possible to use WGS in real-life clinical settings. Furthermore, this platform is applied in the research setting to advance novel therapeutic strategies in cancer and rare diseases. The company’s headquarters is in San Diego (US) with offices in Korea (Seoul and Daejeon) and Hong Kong. To learn more, please visit www.genomeinsight.net

Contact Information:

Steven Esparza

Chief Executive Officer

[email protected]

6193631368

Original Source:

Genome Insight’s Innovative Whole Genome Sequencing Approach to Be Showcased at AACR (American Association of Cancer Research) Annual Meeting 2023

The $50,000 Vilcek Prizes for Creative Promise recognize rising immigrant scientists living and working in the United States whose work represents a significant contribution to their field.

…

The SYNGAP1 Gene: Seeking Treatments and the Genetic Link to Related Neurological Disorders

WASHINGTON, April 17, 2…

CEO Zach Booker also praises Midwest as haven for startups

GRAND RAPIDS, Mich., April 17, 2023 (Newswire.com)
–
In two events at the recent SXSW Conference, ADHD Online, the leader in online ADHD testing and assessment, outlined the reasons for its exponential growth and addressed the unspoken prevalence of mental health issues for entrepreneurs.

“ADHD Online is based in Grand Rapids, Michigan, far from the entrepreneurial hotbeds of the U.S. coasts. But the Midwest is a powerhouse of talent, with unique opportunities, and ADHD Online leveraged the region’s advantages,” CEO Zach Booker told the crowd at the “Scaling in the Midwest” panel. “That allowed the company to grow to serve patients in all 50 states in just one year,” Booker said.  

“Central to that success was the company’s philosophy and structure, which allowed it to ‘plug and play’ a system that delivers and maintains a high standard of care for treating mental health patients in the same way regardless of where they live,” Booker said.  

At the “Mental Health and Entrepreneurs” panel, Keith Brophy, ADHD Online’s chief operating officer, outlined the increasing prevalence of mental health issues in the United States and among entrepreneurs in particular. According to the Centers for Disease Control, one in five Americans will experience a mental illness in a given year, while one in 25 lives with a serious mental illness.  

“Among the factors that can contribute to mental illness are adverse life experiences, substance abuse, trauma, loneliness and isolation – with the latter two being common problems among entrepreneurs as they create and launch their ventures,” Brophy said, citing a number of studies. 

Entrepreneur Online reports found that one in four entrepreneurs will experience mental illness of some kind, with anxiety and depression the most common issues. A recent study found that 72% of entrepreneurs had mental health problems. And statistics from the National Institute for Mental Health show that entrepreneurs have depression at twice the rate of the general population, six times the rate of ADHD, three times the rate of bipolar disorder, and twice the rate of addiction. 

“Our panel really set the stage for entrepreneurs to be open in discussing their mental health and not hiding behind the mystique of entrepreneurs and leaders, where they can’t be authentic about their mental health,” Brophy said.  

“The mental health of entrepreneurs is overlooked, or even swept under the rug,” Booker agreed. “There’s an assumption that people have that entrepreneurs must be good at everything since they’re in business for themselves. And the ‘fake it until you make it’ phenomenon means many entrepreneurs can’t be honest about their struggles.” 

To learn more about ADHD Online and Mentavi Health, visit https://adhdonline.com/. 

About ADHD Online

ADHD Online was founded in 2018 with the mission that everyone should have access to quality ADHD assessments regardless of who and where they are. The ADHD Online team is filled with industry experts across the United States who all share the same passion for ADHD and making sure patients have access to critical mental health services. ADHD Online is leading the way with being a critical voice for those who might be struggling with ADHD and is the only organization to offer HIPAA-secured ADHD assessments online with results from licensed psychologists. ADHD Online is active in all 50 states.

Contact Information:

Mike Albanese

[email protected]

Original Source:

ADHD Online Leaders Address Hidden Issue of Entrepreneurs’ Common Mental Health Challenges

HanchorBio Received IND Clearance of HCB101 Multi-regional Clinical Trial By US FDA

HanchorBio_logo HanchorBio company logo
…

Real-time patient discharge information automatically populates the transitions of care dashboard, transforming Medicare TCM and CCM programs.

HOUSTON, April 17, 2023 (Newswire.com)
–
CrossTx, a leading care management cloud-based technology company serving Rural Health Clinics, Federally Qualified Health Centers and physician-owned clinics with C3HIE, a leading Texas-based health information exchange (HIE) in 129 Texas counties, announce exciting new functionality to a long-standing partnership. This novel approach utilizes the C3HIE Admission, Discharge, and Transfer (ADT) data-feed to support comprehensive Transitional Care Management (TCM) programs across Texas. The new functionality includes a comprehensive dashboard that auto populates discharged patient information from surrounding hospitals which provide a step-by-step transitional care workflow. Throughout the transition process, the software generates a patient specific report and patient population report, complete with audit trails. This collaborative service offering ensures proper care coordination tracking for TCM codes 99496 and 99495, supports ACO shared savings programs, and other quality-based initiatives.

The Centers for Medicare and Medicaid Services (CMS) TCM program helps improve patient outcomes in the transition from an inpatient or partial inpatient setting to community location. With the ADT data-feed from C3HIE, discharged patients are identifiable as well as filtered to focus on eligible Medicare Beneficiaries deemed at risk for readmission or other adverse events following hospitalization. C3HIE’s data provides real-time information on patient discharge status. This data, when placed into CrossTx, supports patient progress while facilitating specific steps in the TCM program including 30 days of care coordination, any necessary adjustments to the care plan, provider chart and discharge review, medicine reconciliation, care coordinator chart and discharge review, documentation of the interactive call, and completed follow up visit within 7 or 14 days after discharge.

“We are excited to expand our partnership with C3HIE to develop a TCM program that improves patient outcomes and reduces healthcare costs,” said Chad Nybo, CEO of CrossTx. “By utilizing the ADT data-feed from C3HIE, our TCM cloud-based service populates eligible patients, in real-time. Our client’s care coordinators can now provide them with the support they need to transition from hospital to home smoothly.”

C3HIE’s ADT data-feed provides timely and accurate information on patient admissions, discharges, and transfers, making it an essential tool for care coordination. “We are thrilled to work with CrossTx to develop a TCM program that leverages our ADT data-feed to improve patient outcomes and reduce readmissions,” said Jim Hoag, COO of C3HIE. “This integrated partnership leverages our provider connections in the HIE ecosystem giving providers revenue-generating tools to improve outcomes for less cost.”

C3HIE and CrossTx have collaborated now for several years to support clinics, community health centers, and other healthcare facilities to develop Chronic Care Management (CCM) programs. CCM programs are designed to support patients with chronic conditions between visits with their provider. TCM programs can increase the enrollment of patients in CCM programs and thereby optimize patient outcomes, reducing costs, and addressing gaps in care within the community. The TCM dashboard would not be complete without a section dedicated to encouraging TCM patients to enroll in the facility’s CCM program for long-term improvement.

About CrossTx: CrossTx is a healthcare technology company that is dedicated to improving the healthcare experience for patients and providers alike. With a focus on innovation and user-centered design, CrossTx develops care coordination solutions that make CMS programs such as Chronic Care Management and Transitional Care Management more efficient, accessible, and effective. www.crosstx.com

About C3HIE: C3HIE is a Texas-based, multi-region collaboration building the safe and secure infrastructure between healthcare providers’ electronic health records (EHRs) making it possible to exchange information across different platforms. C3HIE offers customized health data sharing and analytics solutions aimed at hospitals, providers, health plans and patients that include real-time alerts, historical and predictive analytics, a longitudinal patient health record and community resource collaboration. http://www.C3HIE.org

Contact Information:

Chandra Donnell

VP Client Success

[email protected]

406.595.1326

Original Source:

Texas Health Information Exchange, C3HIE Developed Transitional Care Management Dashboard With CrossTx